Skip to main content

Table 2 Characteristics of 21 patients who did not report a flare at the third and fourth follow-up visit

From: Serial magnetic resonance imaging and ultrasound examinations demonstrate differential inflammatory lesion patterns in soft tissue and bone upon patient-reported flares in rheumatoid arthritis

CharacteristicFollow-up visit 3Follow-up visit 4p value
DAS28CRP2.2 (0.7)2.2 (0.7)0.59
CRP (mg/l)5.2 (6.1)5.1 (7,0)0.82
SJC280.1 (0.4)0.1 (0.4)0.36
TJC281.5 (2.2)1.5 (2.1)0.64
EGA (VAS)4.7 (4.3)4.8 (3.6)0.74
Pain (VAS)16.2 (15.3)15.7 (13.1)0.76
PGA (VAS)18.9 (17.5)15.2 (16.3)0.03
Patient-reported TJC281.0 (1.5)1.0 (1.9)0.80
Patient-reported SJC280.4 (1.1)0.3 (0.7)0.98
HAQ0.4 (0.5)0.4 (0.5)0.22
RA-FQ6.9 (5.3)7.0 (6.6)0.95
MRI synovitis11.0 (3.5)11.5 (3.6)0.92
MRI tenosynovitis6.6 (4.6)6.8 (4.4)0.46
MRI BME3.3 (3.7)3.3 (3.7)0.19
GLOESS9.1 (4.3)9.4 (4.5)0.08
US tenosynovitis3.6 (4.5)4.1 (5.1)0.23
  1. Mean (SD) of clinical, patient-reported, and imaging characteristics. BME bone marrow edema, CRP C- reactive protein, DAS disease activity score, EGA evaluator global assessment, GLOESS Global OMERACT (Outcome Measures in Rheumatology) -EULAR (European League Against Rheumatism) Synovitis Score, HAQ health assessment questionnaire, MRI magnetic resonance imaging, PGA patient’s global assessment, RA-FQ OMERACT Rheumatoid Arthritis Flare Questionnaire, SJC28 swollen joint count in 28 joints, TJC28 tender joint count in 28 joints, US ultrasonography, VAS visual analog scale; p value for paired data comparison between visit 3 and visit 4 assessed by paired t test or Wilcoxon signed-rank test, as appropriate